PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Olmesartan medoxomil/amlodipine/hydrochlorothiazide
Presentation Product Chemical substance Chapter Items dispensed
Generic Sevikar HCT 20mg/5mg/12.5mg tablets
0205052ACAAAAAA
Olmesartan medoxomil/amlodipine/hydrochlorothiazide Olmesartan medoxomil/amlodipine/hydrochlorothiazide Cardiovascular System 5
Generic Sevikar HCT 40mg/5mg/12.5mg tablets
0205052ACAAABAB
Olmesartan medoxomil/amlodipine/hydrochlorothiazide Olmesartan medoxomil/amlodipine/hydrochlorothiazide Cardiovascular System 3
Generic Sevikar HCT 40mg/10mg/12.5mg tablets
0205052ACAAACAC
Olmesartan medoxomil/amlodipine/hydrochlorothiazide Olmesartan medoxomil/amlodipine/hydrochlorothiazide Cardiovascular System 2
Generic Sevikar HCT 40mg/10mg/25mg tablets
0205052ACAAAEAE
Olmesartan medoxomil/amlodipine/hydrochlorothiazide Olmesartan medoxomil/amlodipine/hydrochlorothiazide Cardiovascular System No data available
Generic Sevikar HCT 40mg/5mg/25mg tablets
0205052ACAAADAD
Olmesartan medoxomil/amlodipine/hydrochlorothiazide Olmesartan medoxomil/amlodipine/hydrochlorothiazide Cardiovascular System No data available

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.